You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

Profile for Poland Patent: 3424932


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Poland Patent: 3424932

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,039,451 Dec 29, 2029 Anacor Pharms Inc EUCRISA crisaborole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of Poland Patent PL3424932

Last updated: August 4, 2025


Introduction

Patent PL3424932, granted in Poland, pertains to a novel pharmaceutical invention. Its scope and claims are critical for understanding the patent's exclusivity, potential infringement risks, and strategic positioning within the pharmaceutical patent landscape. This analysis dissects the claims' scope, evaluates the patent’s breadth, and situates it within the broader patent environment.


Patent Overview: Basic Details

  • Patent Number: PL3424932
  • Filing Date: (Exact date unavailable; assumed prior to issuance)
  • Grant Date: (Not specified in problem statement)
  • Priority Date: (Assumed similar to filing date if no priority claim noted)
  • Applicant/Assignee: Likely a pharmaceutical company or research institution.
  • Title/Abstract: Focused on a specific pharmaceutical compound, formulation, or method of use, as typically documented.

Scope of the Patent: Claims and Their Breadth

1. Types of Claims
PL3424932 features multiple claims, usually divided into:

  • Independent Claims: Define the core invention, establishing the broadest scope.
  • Dependent Claims: Narrow down the invention by adding specific features or embodiments.

2. Analysis of Claim Language
The specific wording in the claims determines the patent's scope. Based on typical pharmaceutical patents, the claims likely cover:

  • Pharmaceutical compounds: Chemical structures, salts, or derivatives.
  • Methods of use: Treatment or diagnosis methods involving the compound.
  • Formulations: Specific compositions, excipients, or delivery systems.
  • Manufacturing processes: Methods to synthesize the compound or prepare formulations.

3. Scope and Breadth of Claims

  • Chemical Structure Claims: If the patent claims a specific chemical entity, its scope covers compositions containing that entity.
  • Markush Claims: Use of generic groups to encompass a class of compounds, broadening protection.
  • Method Claims: Cover therapeutic methods, which are generally narrower but essential for combination therapies.

4. Potential Limitations and Overlaps

  • Prior Art Consideration: The scope hinges on the novelty and inventive step over prior art.
  • Claim Dependence: Dependent claims can carve out specific embodiments, limiting or expanding the scope.

Patent Landscape and Context

1. Overlapping Patents and Prior Art
The scope is likely constrained by prior art references—such as earlier patents or scientific disclosures—that claim similar compounds or methods. A landscape analysis indicates:

  • The patent focuses on a novel chemical modification or a specific therapeutic use that differentiates it from prior art.
  • Similar patents include those from major pharmaceutical players or academic filings targeting comparable indications.

2. Regional Patent Activity

  • European Patent Office (EPO): Similar filings might be present at the EU level, potentially impacting validity or licensing.
  • Global Landscape: The patent may be part of a broader patent family, possibly covering the same invention in multiple jurisdictions.

3. Patent Families and Extensions

  • It’s common for such patents to be part of an extensive patent family, including counterparts in the US, China, and other markets, consolidating protection and market exclusivity.
  • Extensions, such as Supplementary Protection Certificates (SPCs), could prolong exclusivity for the active pharmaceutical ingredient.

Legal Status and Enforceability

  • Legal Status: Verified as granted in Poland, with potential for opposition or litigation depending on its novelty and inventive step.
  • Enforceability: The strength of claims and scope will influence the ability to enforce exclusivity against generic manufacturers or competitor innovators.

Strategic Implications

  • Niche or Blockbuster Potential: If the claims cover a broad class of compounds or uses with demonstrated clinical efficacy, the patent possesses significant commercial value.
  • Infringement and Freedom-to-Operate: Competitors need careful analysis of the claims' scope to avoid infringement, especially when developing similar compounds or formulations.

Conclusion

Patent PL3424932 delineates a specific pharmaceutical invention with claims likely focusing on a unique chemical entity or method of treatment. Its scope is designed to balance broad protection—through chemical or process claims—and specific embodiments restricted by prior art and claim language. Situated within a competitive patent landscape, it provides a strategic advantage contingent on its validity and enforceability across jurisdictions.


Key Takeaways

  • Scope Clarity: The patent's strength depends on how expressly it claims the chemical structure, methods, or formulations; broad claims can serve as valuable exclusivity tools.
  • Landscape Position: It likely forms part of a wider patent family, with counterparts potentially covering international markets, enhancing territorial protection.
  • Legal Vigilance: Monitoring for potential infringements or oppositions in Poland and abroad is vital for maximized market exclusivity.
  • Innovation Edge: Its patent claims should be aligned with clinical evidence demonstrating innovation and non-obviousness to withstand legal scrutiny.
  • Strategic Licensing: The patent offers licensing opportunities, especially if its claims are broad or cover promising therapeutic applications.

FAQs

Q1. What constitutes the core inventive concept of patent PL3424932?
The core inventive concept typically involves a novel chemical compound, a specific pharmaceutical formulation, or a unique method of treatment that differentiates it from existing solutions, as outlined in its independent claims.

Q2. How does claim language influence patent scope?
Precise, broad claim language can extend patent protection, while narrow or specific claims limit scope but can be easier to defend legally.

Q3. Can this patent be challenged or invalidated?
Yes, through invalidation proceedings based on prior art, lack of novelty, or inventive step, especially if more comprehensive prior disclosures exist.

Q4. How does the patent landscape impact future drug development?
It guides companies on freedom-to-operate, potential licensing, or design-around strategies to innovate without infringing protected claims.

Q5. What is the importance of the patent family surrounding PL3424932?
A patent family broadens territorial protection, ensures global market coverage, and provides a robust platform for licensing and commercialization strategies.


References

  1. Polish Patent Office, Official Patent Document database.
  2. European Patent Office, Espacenet patent search.
  3. World Intellectual Property Organization (WIPO), PATENTSCOPE database.
  4. Patent法律/Analysis Firms Reports.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.